Rebalix
Logo iSharesiShares · sheet of 10 September 2026
ETF sheet · official issuer and register data

iShares S&P 500 Paris-Aligned Climate UCITS ETF

UPAB · IE00BMXC7V63 · USD · domicile Ireland
Equity · United States · Large cap · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 Net Zero 2050 PAB Sustainability Screened Index
TER
0.07%+ trans. 0.00%
Fund size
319 m EUR
Tracking difference
+0.12%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 22 Apr 2021 · costs from the KID as of 2 Sept 2026 · 266 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the S&P 500 Net Zero 2050 PAB Sustainability Screened Index (Index). The Share Class, via the Fund, is passively managed and aims to invest so far as possible and practicable in the equity securities (e.g. shares) that make up the Index. The Index aims to reflect the performance characteristics of a subset of equity securities within the S&P 500 Index (Parent…

Performance since series start (in euro) — base 100

22 Apr 202131 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2022202320242025202620298200
High 202 (13 Aug 2026) · low 98 (19 May 2021) · last 200. Past performance is not indicative of future results.

Returns in euro

1 year+18.0%
3 years+61.7%
5 years+74.0%
10 yearsseries too young
Since series start+100.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.92%15.22%17.96%
Max drawdown−11.38%−18.99%−28.33%
Sharpe1.031.050.54
Sortino1.481.550.77
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · UPAB · IE00BMXC7V631
RebalixUPAB · IE00BMXC7V63 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+15.37%+15.27%+0.11%
2024+25.64%+25.51%+0.13%
2023+30.27%+30.14%+0.13%
2022−22.73%−22.86%+0.13%

Holdings

Portfolio as declared by the issuer · 31 Aug 2026 · 266 securities · top-10 weight = 45.6%
Top holdingsWeight
NVIDIA10.8%
MICROSOFT8.2%
APPLE5.0%
ALPHABET CLASS A3.8%
AMAZON.COM INC3.2%
VISA CLASS A3.1%
ALPHABET CLASS C3.0%
BROADCOM INC3.0%
MASTERCARD CLASS A2.9%
TESLA INC2.7%
Countries (% of fund)
United States99.7%Ireland0.3%
Sectors (% of fund)
Information Technology41.6%Financials12.6%Communication10.2%Health Care9.8%Consumer Discretionary9.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
UQAB · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.blackrock.com/it/investitori-privati/literature/kiid/eu-priips-ish
Factsheet · www.ishares.com/gls-download/literature/fact-sheet/upab-ishares-s-p-50
Prospectus · www.blackrock.com/it/investitori-privati/literature/prospectus/ishares
The live sheet, always up to date
rebalix.com/en/etf/IE00BMXC7V63
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · UPAB · IE00BMXC7V632